French company Oncodesign joins forces with Mispro Biotech to spur oncology research in Greater Montréal

Montréal, October 16, 2015 – Oncodesign, a world leader in developing and evaluating therapeutic molecules for use in treating cancer and other serious illnesses, announced today the creation of a medical research facility in Greater Montréal. This investment comes on the heels of signing a joint venture agreement with North American company Mispro Biotech Services. he new facility, combined with the opening of a commercial office near Boston, gives Oncodesign new prospects for growth in the North American market. 

Click here for full article.